Phase IIb Trial of Recombinant Novel Coronavirus Vaccine (Ad5-nCoV) in Adults 18 Years of Age and Older, Living With HIV

NCT05005156 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
155
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fundación Huésped

Collaborators